PMC6344191_01
(A-C) Magnetic resonance imaging (MRI) of the patient with diagnosis of recurrence.
medi-98-e13869-g001.jpg
PMC6344191_01_medi-98-e13869-g001.jpg
F1
The patient was followed up regularly after radiotherapy. The brain MRI on March 9, 2018, showed irregular ring enhancement in the left frontal lobe, with a range of about 2.9 x 3.4 x 3.5 cm (Fig. 1 A-C). The patient underwent intracranial tumor resection on March 23, 2018, and postoperative pathology was glioblastoma (GBM), WHO grade
(A-C) Residual tumor present after the reoperation.
medi-98-e13869-g002.jpg
PMC6344191_01_medi-98-e13869-g002.jpg
F2
(A-C) Magnetic resonance imaging (MRI) of the patient 1 month after radiotherapy.
medi-98-e13869-g003.jpg
PMC6344191_01_medi-98-e13869-g003.jpg
F3
Evaluation of cranial enhanced MRI (Fig. 3 A-C) after chemoradiotherapy showed complete remission of remaining intracranial lesions at the end of radiotherapy and 1 month after radiotherapy.